Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
32.7%
% of FTXH's 51 holdings also in XPH
43.2%
% of XPH's 40 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 7.2% | 4.2% | 4.2% |
|
JOHNSON & JOHNSON | 7.3% | 4.0% | 4.0% |
|
BRISTOL-MYERS SQUIBB CO | 7.0% | 3.9% | 3.9% |
|
ELI LILLY & CO | 3.8% | 5.6% | 3.8% |
|
PFIZER INC | 7.0% | 3.8% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to XPH
|
ABBVIE INC | 7.5% |
|
AMGEN INC | 3.7% |
|
CARDINAL HEALTH INC | 3.7% |
|
VERTEX PHARMACEUTICALS INC | 3.6% |
|
REGENERON PHARMACEUTICALS | 3.6% |
|
GILEAD SCIENCES INC | 3.6% |
|
BIOGEN IDEC INC | 3.5% |
|
PFIZER INC | 3.2% |
|
JOHNSON & JOHNSON | 3.2% |
|
BRISTOL-MYERS SQUIBB CO | 3.0% |
FTXH Underweight Relative to XPH
|
REATA PHARMACEUTICALS, INC. CLASS A | -7.9% |
|
ELANCO ANIMAL HEALTH, INC. | -5.2% |
|
CATALENT INC | -4.6% |
|
AXSOME THERAPEUTICS, INC. | -3.9% |
|
ROYALTY PHARMA PLC CLASS A | -3.7% |
|
INTRA-CELLULAR THERAPIES INC | -3.1% |
|
VENTYX BIOSCIENCES, INC. | -3.0% |
 |
PERRIGO CO | -2.7% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -2.3% |
|
CORCEPT THERAPEUTICS INC | -2.2% |